Dr. E Kolb, MD

NPI: 1053497990
Total Payments
$54,692
2023 Payments
$3,700
Companies
9
Transactions
25

Payment Breakdown by Category

Consulting$44,716 (81.8%)
Travel$9,203 (16.8%)
Food & Beverage$773.14 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $44,716 16 81.8%
Travel and Lodging $9,203 2 16.8%
Food and Beverage $773.14 7 1.4%

Top Paying Companies

Company Total Records Latest Year
NOVARTIS PHARMACEUTICALS CORPORATION $29,000 7 $0 (2022)
F. Hoffmann-La Roche AG $9,371 3 $0 (2018)
Janssen Research & Development, LLC $5,400 1 $0 (2021)
SANOFI US SERVICES INC. $5,311 2 $0 (2018)
Regeneron Pharmaceuticals, Inc. $3,316 2 $0 (2023)
National Marrow Donor Program $1,800 5 $0 (2023)
E.R. Squibb & Sons, L.L.C. $227.03 3 $0 (2019)
Kite Pharma, Inc. $183.89 1 $0 (2023)
JAZZ PHARMACEUTICALS INC. $82.77 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,700 4 Regeneron Pharmaceuticals, Inc. ($3,316)
2022 $3,600 5 NOVARTIS PHARMACEUTICALS CORPORATION ($2,000)
2021 $8,400 2 Janssen Research & Development, LLC ($5,400)
2020 $7,000 1 NOVARTIS PHARMACEUTICALS CORPORATION ($7,000)
2019 $12,197 4 Novartis Pharmaceuticals Corporation ($12,000)
2018 $19,753 8 F. Hoffmann-La Roche AG ($9,371)
2017 $41.94 1 E.R. Squibb & Sons, L.L.C. ($41.94)

All Payment Transactions

25 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/08/2023 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $183.89 General
Category: CELLT
03/20/2023 Regeneron Pharmaceuticals, Inc. EYLEA HD (Biological) Consulting Fee Cash or cash equivalent $2,072.50 General
Category: OPHTHALMOLOGY
03/20/2023 Regeneron Pharmaceuticals, Inc. EYLEA HD (Biological) Consulting Fee Cash or cash equivalent $1,243.50 General
Category: OPHTHALMOLOGY
01/25/2023 National Marrow Donor Program Consulting Fee Cash or cash equivalent $200.00 General
10/21/2022 National Marrow Donor Program Consulting Fee Cash or cash equivalent $400.00 General
07/01/2022 National Marrow Donor Program Consulting Fee Cash or cash equivalent $200.00 General
07/01/2022 National Marrow Donor Program Consulting Fee Cash or cash equivalent $200.00 General
05/06/2022 National Marrow Donor Program Consulting Fee Cash or cash equivalent $800.00 General
04/07/2022 NOVARTIS PHARMACEUTICALS CORPORATION KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: ONCOLOGY
10/10/2021 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: ONCOLOGY
06/28/2021 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $5,400.00 General
11/06/2020 NOVARTIS PHARMACEUTICALS CORPORATION KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $7,000.00 General
Category: ONCOLOGY
12/02/2019 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Food and Beverage In-kind items and services $82.77 General
Category: HEMATOLOGY
10/23/2019 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $114.43 General
09/24/2019 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $7,000.00 General
Category: ONCOLOGY
09/24/2019 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $5,000.00 General
Category: ONCOLOGY
11/30/2018 SANOFI US SERVICES INC. NO PRODUCT DISCUSSED (Drug) Consulting Fee Cash or cash equivalent $5,200.00 General
11/30/2018 SANOFI US SERVICES INC. NO PRODUCT DISCUSSED (Drug) Food and Beverage In-kind items and services $111.29 General
08/29/2018 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: ONCOLOGY
06/03/2018 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $70.66 General
05/03/2018 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: ONCOLOGY
03/07/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Travel and Lodging In-kind items and services $8,632.83 General
Category: None
03/07/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Travel and Lodging In-kind items and services $569.67 General
Category: None
03/07/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Food and Beverage In-kind items and services $168.16 General
Category: None
12/09/2017 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $41.94 General

About Dr. E Kolb, MD

Dr. E Kolb, MD is a Pediatrics healthcare provider based in Wilmington, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053497990.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. E Kolb, MD has received a total of $54,692 in payments from pharmaceutical and medical device companies, with $3,700 received in 2023. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($44,716).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Hematology-Oncology, Pediatric Hematology-Oncology
  • Location Wilmington, DE
  • Active Since 10/31/2006
  • Last Updated 07/28/2015
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1053497990

Products in Payments

  • KYMRIAH (Biological) $29,000
  • Non-Covered Product (Drug) $9,371
  • NO PRODUCT DISCUSSED (Drug) $5,311
  • EYLEA HD (Biological) $3,316
  • Yescarta (Drug) $183.89
  • DEFITELIO (Drug) $82.77

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Wilmington